AI biodefense startup characterizing pathogens to counter biological threats; $30M raised, $200M+ valuation per Forbes NBDS 2026.
Defense
Current Valuation
$200M
as of 2026-07
PRIVATE
QL Price
$200M
0% vs last round
QuantLogix's current estimate for Valthos, published 2026-10-14 — in line with the last disclosed round of $200M (2026-07).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$200M
2026-07
weight 0.82
How this price has held up
No round has priced for Valthos since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-14 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Valthos, 2026-10-14 (aa54b5aa6fd22677).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Valthos going public?
No. Valthos is private and has not filed to go public. There is no S-1 on file.
What is Valthos' valuation in 2026?
Valthos is valued at $200M as of Jul 2026. That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Valthos filed an S-1?
No public S-1 is on file for Valthos.
How much has Valthos raised?
Valthos has raised $30M in total.
Is Valthos publicly traded — can you buy Valthos stock?
No. Valthos is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Valthos on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Total Raised
$30M
IPO Status
Private
Fundraising Status
PrivateTotal raised $30M
Vertical Intelligence — Defense / Aerospace
No name-verified federal prime awards for Valthos in the last 36 months on USASpending.gov — revenue may be classified, flow through subcontracts, or be non-US. Absence of a registry match is reported as-is.
Checked usaspending.gov as of 2026-10-06. Re-checked weekly.
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
8
via ashby
Product-build share
75%
engineering, research, product, design
Trajectory
steady
heavy product build — 75% of open roles are product-building functions (engineering/research/product) — 2 of 8 open roles are engineering.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Member of Technical Staff - Software EngineerMember of Technical Staff - Applied AI EngineerMember of Technical Staff - Computational BiologistMember of Technical Staff - Forward Deployed EngineerMember of Technical Staff - Applied Computational BiologistMember of Technical Staff - Design Engineer
Counted from Valthos's live job board as of 2026-09-28; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
DefenseBiotechAI
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-07. Refreshed quarterly.